Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

CNSX:ACT
CNSX:ACTSoftware

Is Rising Revenue But Wider Losses Altering The Investment Case For Aduro Clean Technologies (CNSX:ACT)?

Aduro Clean Technologies Inc. recently reported its second-quarter and six-month results to November 30, 2025, with sales rising to C$122,706 for the quarter and C$167,206 for the half-year, while net losses widened to C$6.46 million and C$12.79 million respectively. The results highlight that revenue is growing from a low base even as basic loss per share from continuing operations has almost doubled year over year, sharpening focus on Aduro’s path toward financial sustainability. We’ll now...
ASX:QOR
ASX:QORSoftware

Qoria’s Valuation After Quarterly Update And Sharp Share Price Reset

Why Qoria’s latest update rattled the market Qoria (ASX:QOR) released its quarterly update with strong recurring revenue metrics, high gross margins, and low churn. However, the share price dropped sharply after investors focused on higher marketing spend and negative free cash flow. See our latest analysis for Qoria. At A$0.355, Qoria’s recent quarterly update has been met with a sharp reset in expectations, with a 7 day share price return of 31.73% decline and a 30 day share price return of...
SEHK:2171
SEHK:2171Biotechs

How CARsgen’s Solid Tumor CAR T Virus Combo Trial Could Reshape Its Story for Investors (SEHK:2171)

Dispatch Bio and CARsgen Therapeutics Holdings announced a clinical collaboration to run a Phase 1 trial in China evaluating DISP-11, combining Dispatch’s Flare platform and DV-10 virus with CARsgen’s approved BCMA-targeting CAR T therapy zevorcabtagene autoleucel in patients with epithelial solid tumors. This pairing of a tumor-specific virus that “paints” a synthetic antigen with an existing CAR T-cell therapy aims to open an immunotherapy path for solid tumors, where treatment options...
SEHK:1258
SEHK:1258Metals and Mining

Why China Nonferrous Mining (SEHK:1258) Is Down 5.0% After Resuming Full Output And Issuing 2026 Guidance

China Nonferrous Mining Corporation Limited recently reported that rehabilitation of the main and auxiliary shafts at Chambishi Southeast Mine was completed in December 2025, allowing the operation to resume full production on 1 January 2026. Alongside this, the company issued 2026 production guidance outlining approximately 484,000 tonnes of overall copper output and diversified by-products, giving investors clearer visibility into future operating volumes and product mix. We will now...